Commentary | Published:

How can drug addiction help us understand obesity?

Nature Neurosciencevolume 8pages555560 (2005) | Download Citation

Subjects

To the degree that drugs and food activate common reward circuitry in the brain, drugs offer powerful tools for understanding the neural circuitry that mediates food-motivated habits and how this circuitry may be hijacked to cause appetitive behaviors to go awry.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Fraenkel, G.S. The raison d'etre of secondary plant substances: these odd chemicals arose as a means of protecting plants from insects and now guide insects to food. Science 129, 1466–1470 (1959).

  2. 2

    Rozin, P. Adaptive food sampling patterns in vitamin deficient rats. J. Comp. Physiol. Psychol. 69, 126–132 (1969).

  3. 3

    Kendler, K.S., Thornton, L.M. & Pedersen, N.L. Tobacco consumption in Swedish twins reared apart and reared together. Arch. Gen. Psychiatry 57, 886–892 (2000).

  4. 4

    Uhl, G.R., Liu, Q.R. & Naiman, D. Substance abuse vulnerability loci: converging genome scanning data. Trends Genet. 18, 420–425 (2002).

  5. 5

    Baessler, A. et al. Genetic linkage and association of the growth hormone secretagogue receptor (ghrelin receptor) gene in human obesity. Diabetes 54, 259–267 (2005).

  6. 6

    Reale, D., Festa-Bianchet, M. & Jorgenson, J.T. Heritability of body mass varies with age and season in wild bighorn sheep. Heredity 83, 526–532 (1999).

  7. 7

    Friedman, J.M. & Leibel, R.L. Tackling a weighty problem. Cell 69, 217–220 (1992).

  8. 8

    Volkow, N.D. & Li, T.K. Drug addiction: the neurobiology of behaviour gone awry. Nat. Rev. Neurosci. 5, 963–970 (2004).

  9. 9

    Kosten, T.A. et al. Acquisition and maintenance of intravenous cocaine self-administration in Lewis and Fischer inbred rat strains. Brain Res. 778, 418–429 (1997).

  10. 10

    Ranaldi, R., Bauco, P., McCormick, S., Cools, A.R. & Wise, R.A. Equal sensitivity to cocaine reward in addiction-prone and addiction-resistant rat genotypes. Behav. Pharmacol. 12, 527–534 (2001).

  11. 11

    Dallman, M.F., Pecoraro, N.C. & la Fleur, S.E. Chronic stress and comfort foods: self-medication and abdominal obesity. Brain Behav. Immunity (in the press).

  12. 12

    Kreek, M.J. & Koob, G.F. Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend. 51, 23–47 (1998).

  13. 13

    Geary, N. Is the control of fat ingestion sexually differentiated? Physiol. Behav. 83, 659–671 (2004).

  14. 14

    Hu, M., Crombag, H.S., Robinson, T.E. & Becker, J.B. Biological basis of sex differences in the propensity to self-administer cocaine. Neuropsychopharmacology 29, 81–85 (2004).

  15. 15

    Volkow, N.D. et al. Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain. Life Sci. 67, 1507–1515 (2000).

  16. 16

    Johanson, C.E., Balster, R.L. & Bonese, K. Self-administration of psychomotor stimulant drugs: the effects of unlimited access. Pharmacol. Biochem. Behav. 4, 45–51 (1976).

  17. 17

    Corrigall, W.A. & Coen, K.M. Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology (Berl.) 99, 473–478 (1989).

  18. 18

    Johnson, J.G., Cohen, P., Kasen, S. & Brook, J.S. Childhood adversities associated with risk for eating disorders or weight problems during adolescence or early adulthood. Am. J. Psychiatry 159, 394–400 (2002).

  19. 19

    Dube, S.R. et al. Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: the adverse childhood experiences study. Pediatrics 111, 564–572 (2003).

  20. 20

    Sarnyai, Z., Shaham, Y. & Heinrichs, S.C. The role of corticotropin-releasing factor in drug addiction. Pharmacol. Rev. 53, 209–243 (2001).

  21. 21

    Swanson, L.W., Sawchenko, P.E., Rivier, J. & Vale, W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36, 165–186 (1983).

  22. 22

    Richard, D., Lin, Q. & Timofeeva, E. The corticotropin-releasing factor family of peptides and CRF receptors: their roles in the regulation of energy balance. Eur. J. Pharmacol. 440, 189–197 (2002).

  23. 23

    Wagner, F.A. & Anthony, J.C. From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology 26, 479–488 (2002).

  24. 24

    Sowell, E.R. et al. Mapping cortical change across the human life span. Nat. Neurosci. 6, 309–315 (2003).

  25. 25

    Adriani, W. et al. Evidence for enhanced neurobehavioral vulnerability to nicotine during periadolescence in rats. J. Neurosci. 23, 4712–4716 (2003).

  26. 26

    Buka, S.L., Shenassa, E.D. & Niaura, R. Elevated risk of tobacco dependence among offspring of mothers who smoked during pregnancy: a 30-year prospective study. Am. J. Psychiatry 160, 1978–1984 (2003).

  27. 27

    Toschke, A.M., Ehlin, A.G., von Kries, R., Ekbom, A. & Montgomery, S.M. Maternal smoking during pregnancy and appetite control in offspring. J. Perinat. Med. 31, 251–256 (2003).

  28. 28

    Mennella, J.A., Griffin, C.E. & Beauchamp, G.K. Flavor programming during infancy. Pediatrics 113, 840–845 (2004).

  29. 29

    Wise, R.A. & Raptis, L. Effects of naloxone and pimozide on initiation and maintenance measures of free feeding. Brain Res. 368, 62–68 (1986).

  30. 30

    Kavaliers, M. & Hirst, M. Slugs and snails and opiate tales: opioids and feeding behavior in invertebrates. Fed. Proc. 46, 168–172 (1987).

  31. 31

    Josefsson, J.O. & Johansson, P. Naloxone-reversible effect of opioids on pinocytosis in Amoeba proteus. Nature 282, 78–80 (1979).

  32. 32

    Di Chiara, G. & Imperato, A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl Acad. Sci. USA 85, 5274–5278 (1988).

  33. 33

    Wise, R.A. & Rompre, P.P. Brain dopamine and reward. Annu. Rev. Psychol. 40, 191–225 (1989).

  34. 34

    Wise, R.A. Dopamine, learning and motivation. Nat. Rev. Neurosci. 5, 483–494 (2004).

  35. 35

    Bozarth, M.A. & Wise, R.A. Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci. 28, 551–555 (1981).

  36. 36

    MacDonald, A.F., Billington, C.J. & Levine, A.S. Alterations in food intake by opioid and dopamine signaling pathways between the ventral tegmental area and the shell of the nucleus accumbens. Brain Res. 1018, 78–85 (2004).

  37. 37

    Zhang, M., Gosnell, B.A. & Kelley, A.E. Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens. J. Pharmacol. Exp. Ther. 285, 908–914 (1998).

  38. 38

    Yeomans, M.R. & Gray, R.W. Opioid peptides and the control of human ingestive behaviour. Neurosci. Biobehav. Rev. 26, 713–728 (2002).

  39. 39

    Cabanac, M. Physiological role of pleasure. Science 173, 1103–1107 (1971).

  40. 40

    Fulton, S., Woodside, B. & Shizgal, P. Modulation of brain reward circuitry by leptin. Science 287, 125–128 (2000).

  41. 41

    Carroll, M.E. in Drugs of Abuse and Addiction: Neurobehavioral Toxicology (eds. Niesink, R.J.M., Jaspers, R.M.A., Kornet, L.M.W. & vanRee, J.M.) 286–311 (CRC Press, Boca Raton, Florida, USA, 1999).

  42. 42

    Shalev, U., Yap, J. & Shaham, Y. Leptin attenuates acute food deprivation-induced relapse to heroin seeking. J. Neurosci. 21, RC129-1–RC129-5 (2001).

  43. 43

    Volkow, N.D., Fowler, J.S. & Wang, G.J. The addicted human brain: insights from imaging studies. J. Clin. Invest. 111, 1444–1451 (2003).

  44. 44

    Volkow, N.D., Fowler, J.S., Wang, G.J. & Swanson, J.M. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol. Psychiatry 9, 557–569 (2004).

  45. 45

    Koob, G.F. et al. Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci. Biobehav. Rev. 27, 739–749 (2004).

  46. 46

    Volkow, N.D. & Fowler, J.S. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb. Cortex 10, 318–325 (2000).

  47. 47

    McFarland, K., Davidge, S.B., Lapish, C.C. & Kalivas, P.W. Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. J. Neurosci. 24, 1551–1560 (2004).

  48. 48

    Porrino, L.J., Lyons, D., Smith, H.R., Daunais, J.B. & Nader, M.A. Cocaine self-administration produces a progressive involvement of limbic, association, and sensorimotor striatal domains. J. Neurosci. 24, 3554–3562 (2004).

  49. 49

    Pijl, H. Reduced dopaminergic tone in hypothalamic neural circuits: expression of a “thrifty” genotype underlying the metabolic syndrome? Eur. J. Pharmacol. 480, 125–131 (2003).

  50. 50

    Wang, G.J. et al. Brain dopamine and obesity. Lancet 357, 354–357 (2001).

  51. 51

    American Diabetes Association et al. Consensus development conference on antipsychotic drugs and obesity and diabetes. J. Clin. Psychiatry 65, 267–272 (2004).

  52. 52

    Gautier, J.F. et al. Differential brain responses to satiation in obese and lean men. Diabetes 49, 838–846 (2000).

  53. 53

    Wang, G.J. et al. Exposure to appetitive food stimuli markedly activates the human brain. Neuroimage 21, 1790–1797 (2004).

  54. 54

    Rolls, E.T. The functions of the orbitofrontal cortex. Brain Cogn. 55, 11–29 (2004).

  55. 55

    Zubieta, J.K. et al. Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. Nat. Med. 2, 1225–1229 (1996).

  56. 56

    Heinz, A. et al. Correlation of stable elevations in striatal μ-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil. Arch. Gen. Psychiatry 62, 57–64 (2005).

  57. 57

    Levine, A.S., Kotz, C.M. & Gosnell, B.A. Sugars: hedonic aspects, neuroregulation, and energy balance. Am. J. Clin. Nutr. 78, 834S–842S (2003).

  58. 58

    National Center for Health Statistics. FASTATS A to Z (2004) <http://www.cdc.gov/nchs/fastats/>.

  59. 59

    Shaham, Y., Shalev, U., Lu, L., De Wit, H. & Stewart, J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl.) 168, 3–20 (2003).

  60. 60

    Bassareo, V. & Di Chiara, G. Differential responsiveness of dopamine transmission to food-stimuli in nucleus accumbens shell/core compartments. Neuroscience 89, 637–641 (1999).

Download references

Acknowledgements

The authors thank C. Kassed for her assistance in preparing the manuscript.

Author information

Affiliations

  1. National Institute on Drug Abuse, National Institutes of Health, Bethesda, 20892, Maryland, USA

    • Nora D Volkow
    •  & Roy A Wise

Authors

  1. Search for Nora D Volkow in:

  2. Search for Roy A Wise in:

Competing interests

The authors declare no competing financial interests.

About this article

Publication history

Published

Issue Date

DOI

https://doi.org/10.1038/nn1452

Further reading